Company: TVRD
Filing Date: 2025-10-20
Form Type: S-1/A
Source: 0001104659-25-100896
Chunk: 308

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-10-20
Form: S-1/A
Chunk 308
---
 ​      | ​ |      — | ​ | ​ | ​ | ​ | ​            | ​ |          — | ​ | ​ | ​ | ​      | ​ |  — | ​ | ​ | ​ | ​                        | ​ |   319 | ​ | ​ | ​ | ​                  | ​ |       — | ​ | ​ | ​ | ​                                 | ​ |   — | ​ | ​ | ​ | ​                         | ​ |     319 | ​ | ​ |
| Net loss                             | ​ | ​ | ​                                     | ​ |          — | ​ | ​ | ​ | ​      | ​ |      — | ​ | ​ | ​ | ​ | ​            | ​ |          — | ​ | ​ | ​ | ​      | ​ |  — | ​ | ​ | ​ | ​                        | ​ |     — | ​ | ​ | ​ | ​                  | ​ | -29,397 | ​ | ​ | ​ | ​                                 | ​ |   — | ​ | ​ | ​ | ​                         | ​ | -29,397 | ​ | ​ |
| Balances as of December 31, 2024     | ​ | ​ | ​                                     | ​ | 29,555,538 | ​ | ​ | ​ | ​      | $ | 85,503 | ​ | ​ | ​ | ​ | ​            | ​ | 19,197,914 | ​ | ​ | ​ | ​      | $ | 19 | ​ | ​ | ​ | ​                        | $ | 1,086 | ​ | ​ | ​ | ​                  | $ | -92,236 | ​ | ​ | ​ | ​                                 | $ |   — | ​ | ​ | ​ | ​                         | $ | -91,131 | ​ | ​ |

The accompanying notes are an integral part of these financial statements. F-6

TABLE OF CONTENTS

Tvardi Therapeutics, Inc. Statements of Cash Flows
(Amounts in thousands)

| ​                                                                           
 ​                                                                           | ​ 
 ​ | ​ 
 ​ | For the Year EndedDecember 31, 
 2024                           |   |         |   | ​ | ​ | 2023 |   |         |   | ​ 
 ​ |
|:----------------------------------------------------------------------------|:--|:--|:-------------------------------|:--|--------:|:--|:--|:--|:-----|:--|--------:|:--|:--|
| Cash flows